Dat Quang Tran
Principal investigator.
Biotech
Built from public records only: federal awards, patents, filings and papers.Is this you? Contact Noair Lab to claim this profile, correct it or hide it.
2015First federal award
$4.8MFederal grants as PI6 awards
0Patents grantedNone matched
0PapersOpenAlex
Federal awards and patents by year
AwardsPatents
6 awards · $4.8M
| Date | Agency | Award | Amount | Company |
|---|---|---|---|---|
| Apr 19, 2022 | NIH | SBIR Phase II Cyclic Orynotides for Systemic MDR Candidiasis | $983K | Oryn Therapeutics, Inc. |
| Apr 21, 2021 | NIH | SBIR Phase II Cyclic Orynotides for Systemic MDR Candidiasis | $992K | Oryn Therapeutics, Inc. |
| Apr 27, 2020 | NIH | SBIR Phase II Cyclic Orynotides for Systemic MDR Candidiasis | $999K | Oryn Therapeutics, Inc. |
| May 6, 2019 | NIH | SBIR Phase II Cyclic Orynotides for Systemic MDR Candidiasis | $285K | Oryn Therapeutics, Inc. |
| Jul 18, 2016 | NIH | SBIR Phase II First-in-Class Macrocyclic Peptide Therapeutic For Rheumatoid Arthritis | $353K | Oryn Therapeutics, Inc. |
| Aug 6, 2015 | NIH | SBIR Phase II First-in-Class Macrocyclic Peptide Therapeutic For Rheumatoid Arthritis | $1.1M | Oryn Therapeutics, Inc. |
Peer ranks
Federal funding#293
Awards as PI#315
Patents#273
Companies
- Oryn Therapeutics, Inc.Linked by awards · Biotech
Federal awards through Oct 21, 2026 and patents through Oct 20, 2026. Awards come from NIH, NSF and other agency records that name a principal investigator; DoD and NASA contract awards do not, so they are not shown here. Researchers are matched by name and company.